Piperacillin-Tazobactam vs. Cefepime for Kidney Injury and Neurologic Dysfunction (ACORN Trial)
PulmCCM
DECEMBER 10, 2023
Over the years, dozens of copycat studies (which are relatively easy for academics to churn out) created a steady, low-quality drumbeat of negativity toward Zosyn. Zosyn seems to have been cleared of all renal wrongdoing and to have won this round against cefepime.
Let's personalize your content